1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Multiple Sclerosis Drugs Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Interferon
        1.2.3 Immunomodulator
        1.2.4 Immunosuppressant
    1.3 Market by Application
        1.3.1 Global Multiple Sclerosis Drugs Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Online Pharmacy
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Multiple Sclerosis Drugs Treatment Market Perspective (2017-2028)
    2.2 Multiple Sclerosis Drugs Treatment Growth Trends by Region
        2.2.1 Multiple Sclerosis Drugs Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Multiple Sclerosis Drugs Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Multiple Sclerosis Drugs Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Multiple Sclerosis Drugs Treatment Market Dynamics
        2.3.1 Multiple Sclerosis Drugs Treatment Industry Trends
        2.3.2 Multiple Sclerosis Drugs Treatment Market Drivers
        2.3.3 Multiple Sclerosis Drugs Treatment Market Challenges
        2.3.4 Multiple Sclerosis Drugs Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Multiple Sclerosis Drugs Treatment Players by Revenue
        3.1.1 Global Top Multiple Sclerosis Drugs Treatment Players by Revenue (2017-2022)
        3.1.2 Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Multiple Sclerosis Drugs Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Multiple Sclerosis Drugs Treatment Revenue
    3.4 Global Multiple Sclerosis Drugs Treatment Market Concentration Ratio
        3.4.1 Global Multiple Sclerosis Drugs Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Multiple Sclerosis Drugs Treatment Revenue in 2021
    3.5 Multiple Sclerosis Drugs Treatment Key Players Head office and Area Served
    3.6 Key Players Multiple Sclerosis Drugs Treatment Product Solution and Service
    3.7 Date of Enter into Multiple Sclerosis Drugs Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Multiple Sclerosis Drugs Treatment Breakdown Data by Type
    4.1 Global Multiple Sclerosis Drugs Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Type (2023-2028)
5 Multiple Sclerosis Drugs Treatment Breakdown Data by Application
    5.1 Global Multiple Sclerosis Drugs Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Multiple Sclerosis Drugs Treatment Market Size (2017-2028)
    6.2 North America Multiple Sclerosis Drugs Treatment Market Size by Type
        6.2.1 North America Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022)
        6.2.2 North America Multiple Sclerosis Drugs Treatment Market Size by Type (2023-2028)
        6.2.3 North America Multiple Sclerosis Drugs Treatment Market Share by Type (2017-2028)
    6.3 North America Multiple Sclerosis Drugs Treatment Market Size by Application
        6.3.1 North America Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022)
        6.3.2 North America Multiple Sclerosis Drugs Treatment Market Size by Application (2023-2028)
        6.3.3 North America Multiple Sclerosis Drugs Treatment Market Share by Application (2017-2028)
    6.4 North America Multiple Sclerosis Drugs Treatment Market Size by Country
        6.4.1 North America Multiple Sclerosis Drugs Treatment Market Size by Country (2017-2022)
        6.4.2 North America Multiple Sclerosis Drugs Treatment Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Multiple Sclerosis Drugs Treatment Market Size (2017-2028)
    7.2 Europe Multiple Sclerosis Drugs Treatment Market Size by Type
        7.2.1 Europe Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022)
        7.2.2 Europe Multiple Sclerosis Drugs Treatment Market Size by Type (2023-2028)
        7.2.3 Europe Multiple Sclerosis Drugs Treatment Market Share by Type (2017-2028)
    7.3 Europe Multiple Sclerosis Drugs Treatment Market Size by Application
        7.3.1 Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022)
        7.3.2 Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2023-2028)
        7.3.3 Europe Multiple Sclerosis Drugs Treatment Market Share by Application (2017-2028)
    7.4 Europe Multiple Sclerosis Drugs Treatment Market Size by Country
        7.4.1 Europe Multiple Sclerosis Drugs Treatment Market Size by Country (2017-2022)
        7.4.2 Europe Multiple Sclerosis Drugs Treatment Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Type
        8.2.1 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Share by Type (2017-2028)
    8.3 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Application
        8.3.1 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Share by Application (2017-2028)
    8.4 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Region
        8.4.1 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Multiple Sclerosis Drugs Treatment Market Size (2017-2028)
    9.2 Latin America Multiple Sclerosis Drugs Treatment Market Size by Type
        9.2.1 Latin America Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022)
        9.2.2 Latin America Multiple Sclerosis Drugs Treatment Market Size by Type (2023-2028)
        9.2.3 Latin America Multiple Sclerosis Drugs Treatment Market Share by Type (2017-2028)
    9.3 Latin America Multiple Sclerosis Drugs Treatment Market Size by Application
        9.3.1 Latin America Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022)
        9.3.2 Latin America Multiple Sclerosis Drugs Treatment Market Size by Application (2023-2028)
        9.3.3 Latin America Multiple Sclerosis Drugs Treatment Market Share by Application (2017-2028)
    9.4 Latin America Multiple Sclerosis Drugs Treatment Market Size by Country
        9.4.1 Latin America Multiple Sclerosis Drugs Treatment Market Size by Country (2017-2022)
        9.4.2 Latin America Multiple Sclerosis Drugs Treatment Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Type
        10.2.1 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Share by Type (2017-2028)
    10.3 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Application
        10.3.1 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Share by Application (2017-2028)
    10.4 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Country
        10.4.1 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Multiple Sclerosis Drugs Treatment Introduction
        11.1.4 Pfizer Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
        11.1.5 Pfizer Recent Developments
    11.2 Roche
        11.2.1 Roche Company Details
        11.2.2 Roche Business Overview
        11.2.3 Roche Multiple Sclerosis Drugs Treatment Introduction
        11.2.4 Roche Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
        11.2.5 Roche Recent Developments
    11.3 Biogen
        11.3.1 Biogen Company Details
        11.3.2 Biogen Business Overview
        11.3.3 Biogen Multiple Sclerosis Drugs Treatment Introduction
        11.3.4 Biogen Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
        11.3.5 Biogen Recent Developments
    11.4 Teva Pharmaceutical
        11.4.1 Teva Pharmaceutical Company Details
        11.4.2 Teva Pharmaceutical Business Overview
        11.4.3 Teva Pharmaceutical Multiple Sclerosis Drugs Treatment Introduction
        11.4.4 Teva Pharmaceutical Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
        11.4.5 Teva Pharmaceutical Recent Developments
    11.5 Merck
        11.5.1 Merck Company Details
        11.5.2 Merck Business Overview
        11.5.3 Merck Multiple Sclerosis Drugs Treatment Introduction
        11.5.4 Merck Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
        11.5.5 Merck Recent Developments
    11.6 Novartis
        11.6.1 Novartis Company Details
        11.6.2 Novartis Business Overview
        11.6.3 Novartis Multiple Sclerosis Drugs Treatment Introduction
        11.6.4 Novartis Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
        11.6.5 Novartis Recent Developments
    11.7 Bayer
        11.7.1 Bayer Company Details
        11.7.2 Bayer Business Overview
        11.7.3 Bayer Multiple Sclerosis Drugs Treatment Introduction
        11.7.4 Bayer Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
        11.7.5 Bayer Recent Developments
    11.8 Sanofi
        11.8.1 Sanofi Company Details
        11.8.2 Sanofi Business Overview
        11.8.3 Sanofi Multiple Sclerosis Drugs Treatment Introduction
        11.8.4 Sanofi Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
        11.8.5 Sanofi Recent Developments
    11.9 Acorda Therapeutics
        11.9.1 Acorda Therapeutics Company Details
        11.9.2 Acorda Therapeutics Business Overview
        11.9.3 Acorda Therapeutics Multiple Sclerosis Drugs Treatment Introduction
        11.9.4 Acorda Therapeutics Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
        11.9.5 Acorda Therapeutics Recent Developments
    11.10 Questcor Pharmaceuticals
        11.10.1 Questcor Pharmaceuticals Company Details
        11.10.2 Questcor Pharmaceuticals Business Overview
        11.10.3 Questcor Pharmaceuticals Multiple Sclerosis Drugs Treatment Introduction
        11.10.4 Questcor Pharmaceuticals Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
        11.10.5 Questcor Pharmaceuticals Recent Developments
    11.11 AbbVie
        11.11.1 AbbVie Company Details
        11.11.2 AbbVie Business Overview
        11.11.3 AbbVie Multiple Sclerosis Drugs Treatment Introduction
        11.11.4 AbbVie Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
        11.11.5 AbbVie Recent Developments
    11.12 Opexa Therapeutics
        11.12.1 Opexa Therapeutics Company Details
        11.12.2 Opexa Therapeutics Business Overview
        11.12.3 Opexa Therapeutics Multiple Sclerosis Drugs Treatment Introduction
        11.12.4 Opexa Therapeutics Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
        11.12.5 Opexa Therapeutics Recent Developments
    11.13 Genzyme Corporation
        11.13.1 Genzyme Corporation Company Details
        11.13.2 Genzyme Corporation Business Overview
        11.13.3 Genzyme Corporation Multiple Sclerosis Drugs Treatment Introduction
        11.13.4 Genzyme Corporation Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022)
        11.13.5 Genzyme Corporation Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Multiple Sclerosis Drugs Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Interferon
    Table 3. Key Players of Immunomodulator
    Table 4. Key Players of Immunosuppressant
    Table 5. Global Multiple Sclerosis Drugs Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Multiple Sclerosis Drugs Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Multiple Sclerosis Drugs Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Multiple Sclerosis Drugs Treatment Market Share by Region (2017-2022)
    Table 9. Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Multiple Sclerosis Drugs Treatment Market Share by Region (2023-2028)
    Table 11. Multiple Sclerosis Drugs Treatment Market Trends
    Table 12. Multiple Sclerosis Drugs Treatment Market Drivers
    Table 13. Multiple Sclerosis Drugs Treatment Market Challenges
    Table 14. Multiple Sclerosis Drugs Treatment Market Restraints
    Table 15. Global Multiple Sclerosis Drugs Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Multiple Sclerosis Drugs Treatment Revenue Share by Players (2017-2022)
    Table 17. Global Top Multiple Sclerosis Drugs Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Sclerosis Drugs Treatment as of 2021)
    Table 18. Ranking of Global Top Multiple Sclerosis Drugs Treatment Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Multiple Sclerosis Drugs Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Multiple Sclerosis Drugs Treatment Product Solution and Service
    Table 22. Date of Enter into Multiple Sclerosis Drugs Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Type (2017-2022)
    Table 26. Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Type (2023-2028)
    Table 28. Global Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Multiple Sclerosis Drugs Treatment Revenue Share by Application (2017-2022)
    Table 30. Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Multiple Sclerosis Drugs Treatment Revenue Share by Application (2023-2028)
    Table 32. North America Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Multiple Sclerosis Drugs Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Multiple Sclerosis Drugs Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Multiple Sclerosis Drugs Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Multiple Sclerosis Drugs Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Multiple Sclerosis Drugs Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Multiple Sclerosis Drugs Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Multiple Sclerosis Drugs Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Multiple Sclerosis Drugs Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Multiple Sclerosis Drugs Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Multiple Sclerosis Drugs Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Multiple Sclerosis Drugs Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Multiple Sclerosis Drugs Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Multiple Sclerosis Drugs Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Multiple Sclerosis Drugs Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Multiple Sclerosis Drugs Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Multiple Sclerosis Drugs Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Multiple Sclerosis Drugs Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Multiple Sclerosis Drugs Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Multiple Sclerosis Drugs Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Multiple Sclerosis Drugs Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Multiple Sclerosis Drugs Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Pfizer Company Details
    Table 63. Pfizer Business Overview
    Table 64. Pfizer Multiple Sclerosis Drugs Treatment Product
    Table 65. Pfizer Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
    Table 66. Pfizer Recent Developments
    Table 67. Roche Company Details
    Table 68. Roche Business Overview
    Table 69. Roche Multiple Sclerosis Drugs Treatment Product
    Table 70. Roche Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
    Table 71. Roche Recent Developments
    Table 72. Biogen Company Details
    Table 73. Biogen Business Overview
    Table 74. Biogen Multiple Sclerosis Drugs Treatment Product
    Table 75. Biogen Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
    Table 76. Biogen Recent Developments
    Table 77. Teva Pharmaceutical Company Details
    Table 78. Teva Pharmaceutical Business Overview
    Table 79. Teva Pharmaceutical Multiple Sclerosis Drugs Treatment Product
    Table 80. Teva Pharmaceutical Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
    Table 81. Teva Pharmaceutical Recent Developments
    Table 82. Merck Company Details
    Table 83. Merck Business Overview
    Table 84. Merck Multiple Sclerosis Drugs Treatment Product
    Table 85. Merck Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
    Table 86. Merck Recent Developments
    Table 87. Novartis Company Details
    Table 88. Novartis Business Overview
    Table 89. Novartis Multiple Sclerosis Drugs Treatment Product
    Table 90. Novartis Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
    Table 91. Novartis Recent Developments
    Table 92. Bayer Company Details
    Table 93. Bayer Business Overview
    Table 94. Bayer Multiple Sclerosis Drugs Treatment Product
    Table 95. Bayer Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
    Table 96. Bayer Recent Developments
    Table 97. Sanofi Company Details
    Table 98. Sanofi Business Overview
    Table 99. Sanofi Multiple Sclerosis Drugs Treatment Product
    Table 100. Sanofi Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
    Table 101. Sanofi Recent Developments
    Table 102. Acorda Therapeutics Company Details
    Table 103. Acorda Therapeutics Business Overview
    Table 104. Acorda Therapeutics Multiple Sclerosis Drugs Treatment Product
    Table 105. Acorda Therapeutics Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
    Table 106. Acorda Therapeutics Recent Developments
    Table 107. Questcor Pharmaceuticals Company Details
    Table 108. Questcor Pharmaceuticals Business Overview
    Table 109. Questcor Pharmaceuticals Multiple Sclerosis Drugs Treatment Product
    Table 110. Questcor Pharmaceuticals Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
    Table 111. Questcor Pharmaceuticals Recent Developments
    Table 112. AbbVie Company Details
    Table 113. AbbVie Business Overview
    Table 114. AbbVie Multiple Sclerosis Drugs Treatment Product
    Table 115. AbbVie Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
    Table 116. AbbVie Recent Developments
    Table 117. Opexa Therapeutics Company Details
    Table 118. Opexa Therapeutics Business Overview
    Table 119. Opexa Therapeutics Multiple Sclerosis Drugs Treatment Product
    Table 120. Opexa Therapeutics Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
    Table 121. Opexa Therapeutics Recent Developments
    Table 122. Genzyme Corporation Company Details
    Table 123. Genzyme Corporation Business Overview
    Table 124. Genzyme Corporation Multiple Sclerosis Drugs Treatment Product
    Table 125. Genzyme Corporation Revenue in Multiple Sclerosis Drugs Treatment Business (2017-2022) & (US$ Million)
    Table 126. Genzyme Corporation Recent Developments
    Table 127. Research Programs/Design for This Report
    Table 128. Key Data Information from Secondary Sources
    Table 129. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Multiple Sclerosis Drugs Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Interferon Features
    Figure 3. Immunomodulator Features
    Figure 4. Immunosuppressant Features
    Figure 5. Global Multiple Sclerosis Drugs Treatment Market Share by Application: 2021 VS 2028
    Figure 6. Hospital Pharmacy Case Studies
    Figure 7. Retail Pharmacy Case Studies
    Figure 8. Online Pharmacy Case Studies
    Figure 9. Other Case Studies
    Figure 10. Multiple Sclerosis Drugs Treatment Report Years Considered
    Figure 11. Global Multiple Sclerosis Drugs Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Multiple Sclerosis Drugs Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Multiple Sclerosis Drugs Treatment Market Share by Region: 2021 VS 2028
    Figure 14. Global Multiple Sclerosis Drugs Treatment Market Share by Players in 2021
    Figure 15. Global Top Multiple Sclerosis Drugs Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Sclerosis Drugs Treatment as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Multiple Sclerosis Drugs Treatment Revenue in 2021
    Figure 17. North America Multiple Sclerosis Drugs Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Multiple Sclerosis Drugs Treatment Market Size Market Share by Type (2017-2028)
    Figure 19. North America Multiple Sclerosis Drugs Treatment Market Size Market Share by Application (2017-2028)
    Figure 20. North America Multiple Sclerosis Drugs Treatment Market Size Share by Country (2017-2028)
    Figure 21. United States Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Multiple Sclerosis Drugs Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Multiple Sclerosis Drugs Treatment Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Multiple Sclerosis Drugs Treatment Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Multiple Sclerosis Drugs Treatment Market Size Share by Country (2017-2028)
    Figure 27. Germany Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Multiple Sclerosis Drugs Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Multiple Sclerosis Drugs Treatment Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Multiple Sclerosis Drugs Treatment Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Multiple Sclerosis Drugs Treatment Market Size Share by Region (2017-2028)
    Figure 37. China Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Multiple Sclerosis Drugs Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Multiple Sclerosis Drugs Treatment Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Multiple Sclerosis Drugs Treatment Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Multiple Sclerosis Drugs Treatment Market Size Share by Country (2017-2028)
    Figure 47. Mexico Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Multiple Sclerosis Drugs Treatment Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Multiple Sclerosis Drugs Treatment Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Multiple Sclerosis Drugs Treatment Market Size Share by Country (2017-2028)
    Figure 53. Turkey Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Pfizer Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
    Figure 57. Roche Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
    Figure 58. Biogen Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
    Figure 59. Teva Pharmaceutical Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
    Figure 60. Merck Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
    Figure 61. Novartis Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
    Figure 62. Bayer Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
    Figure 63. Sanofi Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
    Figure 64. Acorda Therapeutics Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
    Figure 65. Questcor Pharmaceuticals Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
    Figure 66. AbbVie Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
    Figure 67. Opexa Therapeutics Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
    Figure 68. Genzyme Corporation Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed